Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Schedule of Stock Option Activity (Details)

v3.20.4
Stock-Based Compensation - Schedule of Stock Option Activity (Details)
 12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Shares outstanding beginning balance | shares 288,950
Shares granted | shares 132,545
Shares exercised | shares
Shares forfeited or expired | shares (5,817)
Shares outstanding ending balance | shares 415,678
Shares exercisable ending balance | shares 202,206
Shares vested and expected to vest | shares 402,921
Weighted average grant price outstanding beginning balance | $ / shares $ 21.40
Weighted average grant price granted | $ / shares 9.50
Weighted average grant price forfeited or expired | $ / shares 387.10
Weighted average grant price outstanding ending balance | $ / shares 12.50
Weighted average grant price exercisable ending balance | $ / shares 15.20
Weighted average grant price vested and expected to vest | $ / shares $ 12.60
Weighted average remaining contractual period outstanding beginning balance 8 years 9 months 29 days
Weighted average remaining contractual period granted 9 years 3 months 19 days
Weighted average remaining contractual period exercised 0 years
Weighted average remaining contractual period forfeited or expired 0 years
Weighted average remaining contractual period outstanding ending balance 8 years 5 months 12 days
Weighted average remaining contractual period exercisable ending balance 7 years 10 months 28 days
Weighted average remaining contractual period vested and expected to vest 8 years 5 months 5 days
Aggregate instrinsic value outstanding beginning balance | $
Aggregate instrinsic value granted | $
Aggregate instrinsic value exercised | $
Aggregate instrinsic value forfeited or expired | $
Aggregate instrinsic value outstanding ending balance | $
Aggregate instrinsic value exercisable ending balance | $
Aggregate instrinsic value vested and expected to vest | $